NULL
US scrambles for resources in COVID-19 response
According to new IHS Markit data, the United States' shortage of medical supplies is being exacerbated by trade disruptions from…
Polish pharma associations unite in appeal for greater access to biologics
Poland's pricing and reimbursement system has always had a reputation for restrictiveness when it comes to originator therapies, with its…
Challenges with risk sharing in Eastern Europe raised at ISPOR Europe meeting
While attending the ISPOR Europe 2019 meeting in Copenhagen, I came across an interesting discussion of the unique challenges that…
Dynamic reform in International Reference Pricing
The same week that we recently aired our webinar on the impact and risks of international reference pricing (IRP), Slovakia…
ISPOR Europe 2018 Barcelona
We are at ISPOR Europe 2018 in Barcelona, Spain! We look forward to seeing you there! Please look out for…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
HTA adoption in Asian emerging pharma markets
Asia's emerging markets - such as Indonesia, Vietnam, and the Philippines - may provide a significant growth opportunity of pharmaceutical…
Nevermore ignore the role of digital health in health decision making
Here at the opening of the 23rd annual international meeting of ISPOR in Baltimore - 10 years after we started attending…
Value in healthcare: Insights from ISPOR
I am just back from beautiful Glasgow where this week you could see Roger Federer play in a kilt and…
Better diabetes treatment can save Medicaid over $4 billion per year
Diabetes is one of the most prevalent and expensive medical conditions in the US, especially among people with low socio-economic…
Visit us at ISPOR 2017 Glasgow!
We are pleased to announce that we will be at the 20th Annual ISPOR European Congress, 4-8 November, in Glasgow.…